While CUR has been very successful with its science to date, for it to be successful in the market place requires that it establish commercial viability (o/k/a appreciably efficacious results in humans at a reasonable cost) with its products/services. I suspect that glimpses of that may be shown some time in early to mid 2012. Until then, no appreciable gains will be made, imo.
The respect should come from some of the doctors that can understand .
The marketeers know little to nothing .
Interesting after all the hoopla and media attention Avastin was shown as a cancer drug , today I heard it is not worth anything as far as extending life .
On the otherhand , Erbitux the famous drug of Imclone , the company that Martha Stewart went to jail for selling , hearing they would be held up by the FDA , for further testing , is now being used successfully for many types of cancers .